Corticosterone inhibits the lipid-mobilizing effects of oleoyl-estrone in adrenalectomized rats

Endocrinology

Volumn 148, Issue 8, 2007, Pages 4056-4063

  Grasa, Maria Del Mar ^b   Serrano, Marta ^b   Fernández López, José Antonio ^b   Alemany, Marià ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CORTICOSTERONE; ESTRONE OLEATE; GLUCOSE; LEPTIN; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENALECTOMY; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; BODY COMPOSITION; CORTICOSTERONE; DRUG INTERACTIONS; ENERGY METABOLISM; ESTRONE; FEMALE; LIPID METABOLISM; OLEIC ACIDS; RATS; RATS, WISTAR;

EID: 34547117369     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0331     Document Type: Article

References (45)

1. Sanchis D, Balada F, Grasa MM, Virgili J, Peinado J, Monserrat C, Fernández-López JA, Remesar X, Alemany M 1996 Oleoyl-estrone induces the loss of body fat in rats. Int J Obes 20:588-594
2. Grasa MM, Cabot C, Esteve M, Yubero P, Masanés RM, Blay M, Vilà R, López-Martí J, Fernández-López JA, Remesar X, Alemany M 2001 Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. Obes Res 9:202-209
3. Salas A, Remesar X, Esteve M 2007 Oleoyl-estrone treatment activates apoptotic mechanisms in white adipose tissue. Life Sci 80:293-298
4. Remesar X, Fernández-López JA, Blay MT, Savall P, Salas A, Díaz-Silva M, Esteve M, Grasa MM, Alemany M 2002 Effect of oral oleoyl-estrone on adipose tissue composition in male rats Int J Obes 26:1092-1102
5. Grasa MM, Vilà R, Esteve M, Cabot C, Fernández- López JA, Remesar X, Alemany M 2000 Oleoyl-estrone lowers the body weight of both ob/ob and db/db mice. Horm Metab Res 32:246-250
6. Grasa MM, Esteve M, Masanés RM, Yubero P, Blay M, López-Martí J, Cabot C, Vila R, Fernández-Lopez JA, Remesar X, Alemany M 2001 Oral gavage of oleoyl-oestrone has a stronger effect on body weight in male Zucker obese rats than in female. Diabetes Obes Metab 3:203-208
7. Balada F, Sanchis D, Virgili J, Grasa MM, Monserrat C, Fernández-López JA, Remesar X, Alemany M 1997 Effect of the slimming agent oleoyl-estrone in liposomes (Merlin-2) on the body weight of rats fed a cafeteria diet. Arch Physiol Biochem 105:487-495
8. López-Martí J, Díaz-Silva M, Salas A, Grasa MM, Fernández-López JA, Remesar X, Alemany M 2000 Oleoyl-estrone induces the massive los of body weight in Zucker fa/fa rats fed a high-energy hyperlipidic diet. J Nutr Biochem 11:530-535
9. Remesar X, Guijarro P, Torregrosa C, Grasa MM, López J, Fernández-López JA, Alemany M 2000 Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet. Int J Obes 24:1405-1412
10. Blay M, Peinado-Onsurbe J, Grasa MM, Díaz-Silva M, Fernández-López JA, Remesar X, Alemany M 2002 Effect of oral oleoyl-estrone treatment on plasma lipoproteins and tissue lipase and lipase activities of Zucker lean and obese female rats. Int J Obes 26:618-626
11. Díaz-Silva M, Grasa MM, López-Martí J, Fernández-López JA, Remesar X, Alemany M 2003 Effect of oral oleoyl-estrone on the energy balance of diabetic rats. Horm Metab Res 35:471-478
12. Cabot C, Salas A, Ferrer-Lorente R, Savall P, Remesar X, Fernández-López JA. Esteve M, Alemany M 2005 Short-term oral oleoyl-estrone treatment increases plasma cholesterol turnover in the rat. Int J Obes 29: 534-539
13. Grasa MM, Cabot C, Adán C, Vilà R, Esteve M, Estruch J, Fernández-López JA, Remesar X, Alemany M 1998 Effect of adrenalectomy on the slimming activity of liposome-carried oleoyl-estrone in the rat. Int J Obes 22:1225-1230
14. Adán C, Grasa MM, Cabot C, Esteve M, Vilà R, Massanés RM, Estruch J, Fernández-López JA, Remesar X, Alemany M 1999 Short-term treatment with estrone oleate in liposomes (Merlin-2) does not affect the expression of the ob gene in Zucker obese rats. Mol Cell Biochem 197:109-115
15. Cabot C, Grasa MM, Estruch J, Fernández-López JA, Remesar X, Alemany M 1998 Zucker obese rats are insensitive to the CRH-increasing effect of oleoyl-estrone. Brain Res Bull 46:529-534
16. Wang M 2005 The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab 2:3
17. Asensio C, Muzzin P, Rohner-Jeanrenaud F 2004 Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance. Int J Obes 28(Suppl 4):S45-S52
18. de Feo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB 1989 Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 257:E35-E42
19. Brindley DN 1995 Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes 19(Suppl 4):S69-S75
20. Wolf G 2002 Glucocorticoids in adipocytes stimulate visceral obesity. Nutr Rev 60:148-151
21. Hermus ARMM, Sweep CGJ 1990 Cytokines and the hypothalamic pituitaryadrenal axis. J Steroid Biochem Mol Biol 37:867-871
22. Chan O, Chan S, Inouye K, Shum K, Matthews SG, Vranic M 2002 Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. Diabetes 51:1681-1689
23. Ruzzin J, Wagman AS, Jensen J 2005 Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48:2119-2130
24. Korach-Andre K, Gao J, Gounarides JS, Deacon R, Isalma A, Laurent D 2005 Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Am J Physiol 288:E106-E116
25. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B 1997 Glucocorticoids as counterregulatory hormones of leptin - toward an understanding of leptin resistance. Diabetes 46:717-719
26. Sapolsky R, Romero M, Munck A 2000 How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr Rev 21:55-89
27. Folch J, Lees M, Sloane-Stanley GH 1957 A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 232:497-509
28. Rafecas I, Esteve M, Fernández-López JA, Remesar X, Alemany M 1994 Whole rat protein content estimation: applicability to the Nx6.25 method. Brit J Nutr 72:199-209
29. Grasa MM, Cabot C, Adán C, de Matteis R, Esteve M, Cinti S, Fernández-López JA, Remesar X, Alemany M 2001 Corticosteroid-binding globulin synthesis and distribution in rat white adipose tissue. Mol Cell Biochem 228:25-31
30. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD 1998 Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology 139:443-450
31. Devenport L, Knehans A, Sundstrom A, Thomas T 1989 Corticosterone's dual metabolic actions Life Sci 45:1389-1396
32. Wright BE, Porter JR, Browne ES, Svec F 1992 Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obes 16:579-583
33. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gómez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S 2003 Chronic stress and obesity: a new view of "comfort food." Proc Natl Acad Sci USA 100:11696-11701
34. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE 2003 Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469
35. Kantartzis K, Fritsche A, Tschritter O, Thamer C, Haap M, Schäfer S, Stumvoll M, Häring HU, Stefan N 2005 The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 13:1683-1691
36. Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K, Arner P 2004 Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89:1391-1396
37. Grasa MM, Díaz-Silva M, Fernández-López JA, Remesar X, Alemany M 2003 Oleoyl-estrone decreases rat plasma insulin, leptin and adiponectin, lowering muscle and BAT glucose uptake. Int J Obes 27(Suppl 1):S43 (Abstract)
38. Peinado-Onsurbe J, Blay M, Julve J, Fernández-López JA, Remesar X, Alemany M 2001 Lipoprotein lipase and cholesterol transfer activities of lean and obese Zucker rats. Horm Metab Res 33:458-462
39. Nonogaki K, Iguchi A 1997 Stress, acute hyperglycemia, and hyperlipidemia. Role of the autonomic nervous system and cytokines. Tr Endocrinol Metab 8:192-197
40. Biddinger SB, Kahn CR 2006 From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158
41. Esteve M, Savall P, Blay MT, Fernández-López JA, Remesar X, Alemany M 2001 Intestinal handling of an oral oleoyl-estrone gavage by the rat. Life Sci 69:763-777
42. Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H, Miyamoto S, Nakano M, Ogawa H 2003 Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 88:3190-3195
43. Labrie F, Bélanger A, Simard J, Luu-The V, Labrie C 1995 DHEA and peripheral androgen and estrogen formation: intracrinology. Ann NY Acad Sci 774:16-28
44. Okuda H, Saito Y, Matsuoka N, Fujii S 1974 Mechanism of adrenaline-induced lipolysis in adipose tissue. J Biochem 75:131-137
45. 3- adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats. Life Sci 77:2051-2058